Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
HIGH LEVEL TRANSCRIPTION OF A HUMAN GENE IN HTLV POSITIVE T-CELLS: CDNA CLONING AND CHARACTERIZATION
Genetic and Phenotypic Markers of Tumors. Aaronson SA, Frati L, Verna R, eds. New York, Plenum Press, p. 345-55, 1984.. Unique Identifier : AIDSLINE ICDB/85615483 Fazio VM; Manzari V; Frati L; Franchini G; Wong-Staal F; Gallo RC; Istituto di Patologia Generale, Policlinico Umberto I, Universita; degli Studi di Roma, Italy
Abstract:
The transcription of human T lymphocytes infected by human T-cell leukemia/lymphoma virus (HTLV) was analyzed to investigate the influence of HTLV integration in neoplastic transformation and proliferation of T-cells and to detect gene(s) expressed at high levels in these cells. Messenger RNA (mRNA) was extracted and selected from a T-cell line (HUT 102) actively producing HTLV; using this mRNA as a template, a complementary DNA (cDNA) library was constructed and a clone (HT-3) was selected that hybridized specifically with HUT 102 cDNA and not HUT 78. For selection of the HT-3 clone, the cDNA library was analyzed by differential screening with two different probes; homologous radiolabeled cDNA and labeled cDNA obtained from mRNA of HUT 78. This HT-3 clone hybridized specifically to a cellular single species mRNA of approx 2.3 kilobase, produced at detectable levels in lectin-activated T-cells and at very high levels only in HTLV-infected T-cells. Although no certain candidate can be indicated to HT-3 gene product identification, HT-3 may be involved in at least one of the steps related to T-cell growth factor production. The findings suggested that HT-3 gene is a cellular gene, not a proviral sequence, and that it is present in all human DNAs as a single copy per haploid genome, with at least two allelic genotypes among individuals. The correlation between HTLV infection and HT-3 high levels of transcription needs to be investigated. (30 Refs)
Keywords: Cell Line Cell Transformation, Neoplastic *Cloning, Molecular Gene Expression Regulation Human HTLV-BLV Viruses/*GENETICS Interleukin-2/GENETICS Oncogenes T-Lymphocytes/MICROBIOLOGY *Transcription, Genetic MEETING PAPER
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.